Low Total Metanephrine Level: Clinical Significance and Evaluation
A low total metanephrine level has minimal clinical significance and does not require further evaluation in most clinical contexts, as metanephrine testing is designed to detect elevated levels for pheochromocytoma/paraganglioma (PPGL) diagnosis, not to identify low values.
Clinical Context and Interpretation
Low metanephrine levels are not diagnostically useful for ruling out any specific disease state. The primary purpose of measuring plasma or urinary metanephrines is to detect elevations that suggest catecholamine-secreting tumors 1. Guidelines emphasize that biochemical testing should be initiated when there is clinical suspicion for PPGL, and imaging should only proceed once there is "clear biochemical evidence" of elevated metanephrines 1.
When Low Metanephrines May Have Meaning
The only clinically relevant scenario where low metanephrine levels carry significance is:
Type 1 diabetes with impaired hypoglycemic response: Approximately 25% lower plasma metanephrine levels reflect decreased adrenomedullary epinephrine stores and reduced capacity to secrete epinephrine during hypoglycemia 2. This is a specialized research finding with limited practical clinical application.
Non-functional PPGLs: In the context of known PPGL, "non-functionality is defined as normal plasma and urinary normetanephrine and/or MTY or as plasma metanephrines that are too low according to tumor size" 3. However, this applies to patients with already diagnosed tumors, not to screening scenarios.
What NOT to Do
Do not pursue further workup for low metanephrine values in the following situations:
- Incidental finding on routine testing without clinical suspicion for PPGL
- Patients without hypertension, adrenal masses, or catecholamine excess symptoms
- Screening in asymptomatic individuals
Key Clinical Pitfalls
False Reassurance in Malignant PPGLs
One important caveat: Malignant PPGLs may be less frequently metanephrine-secreting 4. Tumors larger than 5.7 cm with lack of metanephrine secretion are independent predictors of malignancy 4. Therefore, in patients with large adrenal masses (>5.7 cm), normal or low metanephrines do not exclude malignant PPGL—imaging and other evaluation remain necessary.
Medication and Physiological Factors
Multiple medications can lower metanephrine measurements, including:
- Antidepressants
- Glucocorticosteroids
- Non-metformin antidiabetic drugs 5
However, these medication effects are only clinically relevant when interpreting elevated values, not low ones.
Recommended Approach
For a patient with low total metanephrine levels:
Review the indication for testing: Was there appropriate clinical suspicion (hypertension with spells, adrenal incidentaloma, family history of PPGL)?
If testing was appropriate but levels are low: No further biochemical testing needed. The negative predictive value of normal metanephrines is excellent for excluding PPGL.
If an adrenal mass is present: Proceed with standard adrenal incidentaloma evaluation focusing on imaging characteristics and other hormonal assessments (cortisol, aldosterone if indicated), but recognize that large masses (>5.7 cm) may still require surgical evaluation regardless of metanephrine levels 4.
Document and move on: Low metanephrines effectively exclude catecholamine-secreting tumors in appropriate clinical contexts 1.
The bottom line: Low metanephrine levels require no action in the vast majority of clinical scenarios and should not trigger additional testing or specialist referral.